
#1 sorry I can’t respond directly to comments, long term problem - research institutions have stated that they do not plan to ever include us in those studies. So just do it. PrEP has been studied in cis women, cis men, and trans women, and it’s safe for all those groups, meaning there is a low likelihood we will have significant differences in tolerance. (The main issue is likely efficacy in dosing being off for trans men)